Maple syrup urine disease (MSUD): Screening for known mutations in Italian patients
暂无分享,去创建一个
G. Diamond | E. Rappaport | P. Fortina | S. Surrey | A. Iolascon | A. Burlina | C. Dionisi-Vici | R. Parini | M. Sartore | A. Ponzone | O. Guardamagna | R. Heidenreich | R. Cerone | T. Parrella | Alberto Ponzone | R. Cerone | Alberto Burlina | Saul Surrey | Rossella Parini | Carlo Dionisi‐Vici | Eric F. Rappaport | Paolo Fortina
[1] J. Chuang,et al. Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex. , 1994, American journal of human genetics.
[2] F. Peinemann,et al. Molecular genetic characterization of maple syrup urine disease in European families. , 1993, Biochemical medicine and metabolic biology.
[3] C. Arizmendi,et al. Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Chuang,et al. Characterization of the promoter-regulatory region and structural organization of E1α gene (BCKDHA) of human branched-chain α-keto acid dehydrogenase complex , 1993 .
[5] C. W. Fisher,et al. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations. , 1993, American journal of human genetics.
[6] D. Chuang,et al. Structure of the gene encoding dihydrolipoyl transacylase (E2) component of human branched chain alpha-keto acid dehydrogenase complex and characterization of an E2 pseudogene. , 1992, The Journal of biological chemistry.
[7] D. Danner,et al. Nucleotide sequence of the 5' end including the initiation codon of cDNA for the E1α subunit of the human branched chain α-ketoacid dehydrogenase complex , 1992 .
[8] D. Chuang,et al. The complete cDNA sequence for dihydrolipoyl transacylase (E2) of human branched-chain alpha-keto acid dehydrogenase complex. , 1992, Biochimica et biophysica acta.
[9] D. Danner,et al. Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease. , 1992, Biochimica et biophysica acta.
[10] Y. Nobukuni,et al. Gene analysis of mennonite maple syrup urine disease kindred using primer-specified restriction map modification , 1992, Journal of Inherited Metabolic Disease.
[11] C. W. Fisher,et al. Occurrence of a Tyr393----Asn (Y393N) mutation in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population. , 1991, American journal of human genetics.
[12] Y. Nobukuni,et al. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease. , 1991, The Journal of clinical investigation.
[13] J. Weber,et al. Molecular genetic basis of maple syrup urine disease in a family with two defective alleles for branched chain acyltransferase and localization of the gene to human chromosome 1. , 1991, American journal of human genetics.
[14] C. W. Fisher,et al. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex. , 1991, Molecular biology & medicine.
[15] C. W. Fisher,et al. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34. , 1991, Biochemical and biophysical research communications.
[16] Y. Nobukuni,et al. A T-to-A substitution in the E1α subunit gene of the branched-chain α-ketoacid dehydrogenase complex in two cell lines derived from menonite maple syrup urine disease patients , 1990 .
[17] Y. Nobukuni,et al. Maple syrup urine disease: Complete primary structure of the E1β subunit of human branched chain α-ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease , 1990 .
[18] R. Harris,et al. Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease. , 1989, The Journal of clinical investigation.
[19] E. McCabe,et al. DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening , 1987, Human Genetics.
[20] K. G. Cook,et al. Resolution and reconstitution of bovine kidney branched-chain 2-oxo acid dehydrogenase complex. , 1985, The Biochemical journal.
[21] S. Heffelfinger,et al. Identification of specific subunits of highly purified bovine liver branched-chain ketoacid dehydrogenase. , 1983, Biochemistry.
[22] Purification and characterization of branched chain α-keto acid dehydrogenase complex of bovine kidney , 1979, Proceedings of the National Academy of Sciences.
[23] L. Reed,et al. Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[24] Y. Nobukuni,et al. Complete Primary Structure of the ElS Subunit of Human Branched Chain a-Ketoacid Dehydrogenase Complex Deduced from the Nucleotide Sequence and a Gene Analysis of Patients with This Disease , 1990 .
[25] L. Reed,et al. Regulation of mammalian pyruvate and branched-chain alpha-keto acid dehydrogenase complexes by phosphorylation-dephosphorylation. , 1985, Current topics in cellular regulation.